Please login to the form below

Not currently logged in
Email:
Password:

Catalent

This page shows the latest Catalent news and features for those working in and with pharma, biotech and healthcare.

EU concludes discussions with Moderna for COVID-19 vaccine

EU concludes discussions with Moderna for COVID-19 vaccine

In parallel, we are scaling up our manufacturing capability with our strategic partners, Lonza, Catalent and Rovi, to address this global health emergency with a safe and effective vaccine,” said Stéphane

Latest news

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    to deficiencies at the plant operated by Catalent [its CMO].

  • Deal Watch January 2016 Deal Watch January 2016

    Last up, with a headline value of $619m, is Roche's option deal with Catalent/Redwood. ... 750. Catalent| Redwood Bioscience/ Roche. Research collaboration. Non-exclusive access to Redwood's SMARTag platform with an option to commercial licences to

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics